News
-
-
PRESS RELEASE
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
ONWARD Medical reports strong first half 2026 results with robust revenue growth and pipeline progress. Financial highlights include EUR 4.2M revenue and EUR 81.5M cash balance. CEO Dave Marver highlights successful ARC-EX System launch -
-
-
-
-
-
-
-
PRESS RELEASE
ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones
ONWARD Medical announces full year 2025 financial results with strong US commercial performance and major pipeline milestones. Company sells 117 ARC-EX Systems, reports EUR 5.4M in revenue, and raises EUR 50.8M in equity capital